Share Name Share Symbol Market Type Share ISIN Share Description
Proactis Holdings Plc LSE:PHD London Ordinary Share GB00B13GSS58 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 36.00 4,000 08:00:19
Bid Price Offer Price High Price Low Price Open Price
35.00 37.00 36.00 35.50 36.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 54.14 -25.82 -27.90 34
Last Trade Time Trade Type Trade Size Trade Price Currency
13:44:26 O 2,000 35.15 GBX

Proactis (PHD) Latest News

More Proactis News
Proactis Takeover Rumours

Proactis (PHD) Discussions and Chat

Proactis Forums and Chat

Date Time Title Posts
14/7/202013:01PROACTIS Holdings PLC9,977
11/5/201919:08Rodneey Potts2
09/4/201910:27Proactis (PHD) HSBC UK to bring new technology to the market3
03/11/200817:39Proactis, Major product upgrade3

Add a New Thread

Proactis (PHD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-07-13 14:13:4936.2527,5869,999.93O
2020-07-13 14:11:5436.0027,7779,999.72O
View all Proactis trades in real-time

Proactis (PHD) Top Chat Posts

Proactis Daily Update: Proactis Holdings Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker PHD. The last closing price for Proactis was 36p.
Proactis Holdings Plc has a 4 week average price of 35.50p and a 12 week average price of 20.50p.
The 1 year high share price is 63p while the 1 year low share price is currently 14p.
There are currently 95,532,628 shares in issue and the average daily traded volume is 205,041 shares. The market capitalisation of Proactis Holdings Plc is £34,391,746.08.
p1nkfish: 30/4 - Thought this had already been posted. Having listened more than once my posts above are my interpretation of the information taken in the round from my notes. I listened a few times and joined up the dots. Decent Q&A at the end. Notice the question from Libereum, N+1 etc but since the presentation only DBAY buying in volume with a firm limit set for their buy upto price. This must be on the watchlist of a few ii's but until there is more certainty I don't see them jumping in. The Proactis RNS confirming the business level since is re-assuring but note the caution if the virus impacts for too long as they will see multi-months of reduced new signings but fortunately zero churn too. They were confirming 2020 is in the bag - hence the RNS - but sensibly signalling caution if the virus lasts too long. Also caution on bePayd due to the uptake in uncertain times and reduced supply side activity during this period. Confirmed it's at MVP and unique. Interesting he mentioned 2 things I missed for bePayd. 1) Late payers are a margin risk - pretty obvious but I missed that. 2) Solvency of buyer is a risk - heightened during lockdown. Missed that, obvious though. My interpretation is, I consider, straight down the middle. I hold but won't talk things up, just post what I see and think. After this is cleared up expect targets of towards £50M ARR on US and DE/FR each. This will be rocket fuel but realistically it's 2-3 yrs out imho. bePayd a bonus on top. He mentions separating out DE & FR numbers in future as seperate management teams. The ARR, in my opinion, is there for the taking if they have the right people and incentives but first need to clear what may be a weak start to FY21 and my experience has been (elsewhere) churn has low lead-time and can happen in days. A new sales cycle can be 3-18 months, hence potential dip in performance. He mentions timings for sales cycle etc. The base expenses will increase with ARR but not by much imho so new business in US/DE/FR can be lucrative upside. Growth in rev and net income, add a re-rating and I expect a much higher share price but not for a while still. Do you think the same? What do you think? I hold but weakness would not be a surprise and DBAY will take advantage and may be able to do so at < 35p imho. A sell of the company at low valuation would be a travesty as much hard work is completed. Note he mentions no more M&A and it had been a successful strategy until their one rather large mistake - Perfect Commerce but he didn't mention the name specifically so imho. A confession there. All in it's positive but not a quick 3-6 bagger from here. Buying on clarity of new business vs churn might be sensible but it could have moved by then. If the TU mentions weak new signings it could droop. Https://
kirk 6: A lot of people thought there was a placing any minute however due to the reset of their banking facilities with HSBC we are now in a much stronger position than when the share price was 50p. With business pretty much as usual and a share price of 26p, over the coming few weeks there is at least 100% upside as bepayd is rolled out. If we get a bepayd update then I expect 200-300% upside from today's depressed share price
p1nkfish: I think it's you 97p! Whatthe can't buy the others except Coupa as they are all privately held and would need a stake in PE that has other holdings too and so diluting exposure. In terms of share price, Coupa has grown less in share price since float than Proactis did. Granted it's still up but it's not apples-apples and is not a direct comparison. It is on a high rating, looks like on cusp of breakout - go buy it. I prefer the unloved turnaround story that can start a new uptrend, but I'm weird compared to whatthe and strawberry person. Best thing dissatisfied people can do is sell and be happy. Move on to where the grass is greener. Sad to hang round here when so bitter & dissatisfied. Same as an employee, if so bitter just go before you get pushed.
p1nkfish: Looking over the SEC portfolio PHD is by far their poorest performer. A couple of others are down but PHD is head and shoulders the black sheep. New manager = new broom. Headline metrics will improve if they dump PHD unless they believe a come back to £9,308K portfolio valuation plus inflation is possible. First investment was Nov 2017. At 6.4% of 95.5M shares and £9.308M valuation = £1.52 approx as needed share price before inflation. My suspicion is AIFM will look to sell down PHD unless totally convinced there is a real chance of substantial recovery. Will this be dribs and drabs or some decent sized transfer? Dyor.
bernymadoff: The legal process for a takeover isn't long or drawn out nor does it involve reinventing the wheel. When the offer is announced it will be swiftly followed by a scheme of arrangement (usually 2 to 3 weeks afterwards). That SOA will spell out the necessary steps for the transfer of PHD stock to the buyer. It will include the date for a GM at which the shareholder vote will take place. If you look at other companies the whole process from offer to delisting doesn't take more than a month or two. However, the important thing is that once an offer is announced and it's at a substantial premium to the share price the share price will instantly be marked up to within a fraction of the offer price and any holders can cash in their chips. If however they want to get the full offer price they'll have to wait until the sale process is formally completed.
weatherman: ACSO was once very highly rated, and yet its growth slowed. The share price fell, and continues to fall - net debt near zero. PHD has fallen, and now looking for a period of return to growth with debt falling and repayment under control. Different fish. But the cynic might say that these extended periods of expressions of interest are designed to shore up the share price in times of weakness or shorting. Why does it take over 6 months to do due diligence and decide whether you wish to strike a deal? PHD is becoming undervalued on fundamentals if there is return to growth and strengthen profit margins, and I think should rise if cancelled deal.
multibagger: The reviewing tool of previous posts.... multibagger2 Sep '19 - 17:43 - 4903 of 6440 Edit 0 0 0 Wrong conclusion 74tom ! My revised and reduced target is based on market sentiment that is becoming clearer - some may choose to ignore it. I correctly called the subdued/poor sentiment based on the trading update that some posters were raving about. Much as many on here would like to think that their opinions are the only valid, legitimate and considered ones, the market is the final arbiter of the share price So far, the share price trend is not supporting the lofty takeover prices that people were hoping for. Time will tell, whose call was right or wrong. I have been in the market for close to 3 decades or so and been posting on Advfn since 2001. I have learnt a thing or two about the market - I am far from being a perfect investor though, and humble enough to recognise it. DoI: I last held PHD in 2016 - so what happens to the share price now, good or bad is immaterial to me. I have no agenda. I only post to keep track of my thoughts and how those perceptions came to be - to learn from in a reflective manner. BBs are a good repository to go back and check whether intuitions/decisions were right.
fuji99: What does not look logical or fair to me is when one compares the 2017/2018 numbers. In 2017 they made a loss of £2.7 million with EPS = -5.7p on turnover of 25.4 million and yet the share price was hoovering within 150p - 200p band. In 2018 they doubled turnover to 52 million with profit of +3.75 million and EPS = +5.3p. In 2019 they acquired a Dutch company and are signing more contracts than before and yet the share price was below 50p for most of the year. I cannot see any market logic behind this especially when we compare to similar size companies. Now we have a company with revenues more than market cap. Thus why I think this is too much undervalued for 2019 if we take into account the additional income they have compared to previous years. IMO the 2019 results alone will adjust its share price to over £1. Then comes the other parameter of the equation: At what share price will it be taken over ?
pj0077: Crikey.. has anyone seen the PHD share price today?!It's going downhill faster than Eric Pickles in a wheelie-bin!
74tom: @Kirk, I agree your financial position is completely irrelevant. What is relevant is that you think you own 1.1m shares via a CFD, and have been boasting about this for the past few months! You have a bet with IG or another counterparty based on the movement of the PHD share price, IG don’t go out and buy shares in all the companies that it’s customers bet on! So at least your fictional “top slice” of 300,000 “shares” won’t have had any impact on the share price or fed any II’s. You have made yourself look like a complete tool though. Here’s a link to the IG homepage so you can educate yourself on how CFD’s work; hxxps://
Proactis share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200714 14:17:32